These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12544513)

  • 1. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A.
    Dandara C; Masimirembwa CM; Magimba A; Kaaya S; Sayi J; Sommers DK; Snyman JR; Hasler JA
    Pharmacogenetics; 2003 Jan; 13(1):55-8. PubMed ID: 12544513
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Walia HK; Singh N; Sharma S
    Pharmacogenomics; 2022 Jan; 23(2):97-118. PubMed ID: 34911343
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
    Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans.
    Bell DA; Taylor JA; Butler MA; Stephens EA; Wiest J; Brubaker LH; Kadlubar FF; Lucier GW
    Carcinogenesis; 1993 Aug; 14(8):1689-92. PubMed ID: 8102597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.
    Hein DW; Doll MA
    Pharmacogenomics; 2012 Jan; 13(1):31-41. PubMed ID: 22092036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.
    Deloménie C; Sica L; Grant DM; Krishnamoorthy R; Dupret JM
    Pharmacogenetics; 1996 Apr; 6(2):177-85. PubMed ID: 9156695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.
    Aklillu E; Carrillo JA; Makonnen E; Bertilsson L; Djordjevic N
    Eur J Clin Pharmacol; 2018 Jul; 74(7):903-911. PubMed ID: 29589062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.
    Borlak J; Reamon-Buettner SM
    BMC Med Genet; 2006 Jul; 7():58. PubMed ID: 16827944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
    Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
    Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus.
    Santos EC; Pinto AC; Klumb EM; Macedo JM
    Rev Bras Reumatol Engl Ed; 2016; 56(6):521-529. PubMed ID: 27914600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in N-acetylation genotypes between Caucasians and Black South Africans: implications for cancer prevention.
    Loktionov A; Moore W; Spencer SP; Vorster H; Nell T; O'Neill IK; Bingham SA; Cummings JH
    Cancer Detect Prev; 2002; 26(1):15-22. PubMed ID: 12088198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
    Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
    Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children.
    Zielińska E; Niewiarowski W; Bodalski J
    Eur J Clin Pharmacol; 1998; 54(9-10):779-85. PubMed ID: 9923584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity.
    Njagi LN; Mecha JO; Mureithi MW; Otieno LE; Nduba V
    BMC Med Genomics; 2024 Jan; 17(1):14. PubMed ID: 38184575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
    Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
    J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers.
    Jarrar YB; Ismail S; Irshaid YM
    Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
    Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
    Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.